HEALTHEQUITY, INC. financials

  1. Home
  2. Financials
  3. HQY
HQY CIK 0001428336

Source: EDGAR filings · Built 2026-06-03T02:26:45Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow 455.13M 337.77M 241.13M 147.28M 132.09M 168.53M
EBITDA 477.11M 324.79M 270.78M 170.26M 112.95M 149.92M
Working Capital 355.43M 321.43M 440.35M 251.83M 198.15M 255.48M
Net Debt 682.55M 812.57M 529.16M 740.22M 782.82M 746.17M
Gross Margin 69.52% 64.78% 62.29% 57.09% 56.14% 56.62%
Operating Margin 24.55% 13.53% 11.77% 1.05% -3.20% 4.64%
Net Margin 16.38% 8.06% 5.57% -3.03% -5.85% 1.20%
Return on Equity (ROE) 10.21% 4.57% 2.74% -1.38% -2.39% 0.64%
Return on Assets (ROA) 6.37% 2.80% 1.76% -0.85% -1.43% 0.33%
Current Ratio 3.27× 3.06× 4.76× 2.92× 2.29× 2.25×
Debt-to-Equity 0.48× 0.52× 0.46× 0.52× 0.54× 0.78×
Effective Tax Rate 22.43% 16.66% 25.76% 31.38% 33.64% -113.38%
Cash Conversion Ratio 2.12× 3.51× 4.36× -5.76× -3.18× 20.56×
Accruals Ratio -0.07× -0.07× -0.06× -0.06× -0.06× -0.06×
SBC % of Revenue 5.56% 8.04% 7.72% 7.27% 6.97% 5.84%
CapEx Coverage 232.15× 163.08× 143.34× 44.69× 15.83× 13.87×
Free Cash Flow Per Share $5.20 $3.80 $2.77 $1.74 $1.59 $2.23

Valuation Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
P/E Trailing (Diluted) 34.83× 101.30× 118.09× — — 696.25×
P/FCF 16.47× 29.04× 27.26× 34.89× 33.63× 37.52×
FCF Yield 6.07% 3.44% 3.67% 2.87% 2.97% 2.67%
EV / EBITDA 16.69× 31.92× 25.99× 34.64× 46.57× 47.98×
P/S 5.54× 7.96× 6.51× 5.99× 5.92× 8.79×
P/B 3.46× 4.52× 3.20× 2.72× 2.42× 4.68×

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 1.31B 1.20B 999.59M 861.75M 756.56M 733.57M
Cost of Goods and Services Sold 400.31M 422.51M 376.95M 369.81M 331.79M 318.24M
Gross Profit 913.12M 777.26M 622.64M 491.94M 424.76M 415.33M
Research and Development Expense 262.51M 239.51M 218.81M 193.38M 157.36M 124.81M
Operating Expenses 590.66M 614.92M 504.94M 482.88M 449.00M 381.32M
Operating Income (Loss) 322.46M 162.33M 117.70M 9.06M -24.24M 34.01M
Income Tax Expense (Benefit) 62.23M 19.33M 19.33M -11.95M -22.45M -4.69M
Net Income (Loss) Attributable to Parent 215.20M 96.70M 55.71M -26.14M -44.29M 8.83M
Earnings Per Share, Basic $2.50 $1.11 $0.65 $-0.31 $-0.53 $0.12
Weighted Average Number of Shares Outstanding, Basic 86.13M 86.87M 85.56M 84.44M 83.13M 74.23M
Earnings Per Share, Diluted $2.46 $1.09 $0.64 $-0.31 $-0.53 $0.12
Weighted Average Number of Shares Outstanding, Diluted 87.47M 88.83M 86.96M 84.44M 83.13M 75.68M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 318.93M 295.95M 403.98M 254.27M 225.41M 328.80M
Assets, Current 512.28M 477.75M 557.44M 382.89M 351.34M 460.18M
Assets 3.38B 3.45B 3.16B 3.09B 3.11B 2.71B
Long-term Debt 957.38M 1.06B 874.97M 925.34M 930.83M 986.72M
Liabilities, Current 156.85M 156.32M 117.09M 131.06M 153.19M 204.70M
Long-term Debt, Excluding Current Maturities 957.38M 1.06B 874.97M 907.84M 922.08M 924.22M
Liabilities 1.27B 1.33B 1.13B 1.19B 1.25B 1.33B
Stockholders' Equity Attributable to Parent 2.11B 2.11B 2.04B 1.90B 1.85B 1.38B
Common Stock, Shares, Outstanding 85.01M 86.54M 86.13M 84.76M 83.78M 77.17M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities 457.09M 339.86M 242.83M 150.65M 141.00M 181.62M
Payments to Acquire Property, Plant, and Equipment 1.97M 2.08M 1.69M 3.37M 8.91M 13.09M
Net Cash Provided by (Used in) Investing Activities -47.14M -505.45M -46.07M -119.13M -639.25M -96.96M
Payments for Repurchase of Common Stock 299.25M 121.49M 0 0 — —
Net Cash Provided by (Used in) Financing Activities -386.98M 57.57M -47.04M -2.67M 394.86M 52.42M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (HQY CIK 0001428336), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RMD

ResMed Inc.

AXS

AXIS CAPITAL HOLDINGS LIMITED

HTB

HOMETRUST BANCSHARES, INC.